2025 annual financial data
Fennec Pharmaceuticals 2025 Operating margin
Fennec Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was -14.22%.
Operating income was -6,346,000 USD and net income was -9,741,000 USD.
Operating cash flow was -12,473,000 USD.
Get free Fennec Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 44,642,000 USD
- Operating income
- -6,346,000 USD
- Net income
- -9,741,000 USD
- Operating cash flow
- -12,473,000 USD